Published on 30 September 2013
Latest features in GaBI Journal, 2013, Issue 3
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2013.0203.032
4.398 views
Published on 30 September 2013
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2013.0203.032
4.398 views
Published on 11 January 2024
Author(s): Sarah Schrieber, PharmD
DOI: 10.5639/gabij.2023.1203.016
4.280 views
Published on 18 March 2014
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2014.0301.001
4.205 views
Published on 08 September 2022
biosimilars, interchangeability, substitution, switching, US
DOI: 10.5639/gabij.2022.1103.016
4.180 views
Published on 31 October 2016
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2016.0504.049
4.115 views
Published on 14 December 2016
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2016.0504.050
4.093 views
Published on 28 October 2019
Author(s): Maria Fabiana Jorge, MBA
access to medicines, biosimilars, generic drugs, trade agreements, USMCA
DOI: 10.5639/gabij.2020.0901.005
4.086 views
Published on 27 September 2017
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2017.0603.028
4.058 views
Published on 28 October 2019
Author(s): Zorana Maravic, BSc, MBA
biosimilars, colorectal cancer, digestive cancers, patients, position paper
DOI: 10.5639/gabij.2019.0803.017
3.994 views
Published on 04 July 2016
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2016.0502.013
3.966 views
Published on 12 March 2015
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2014.0304.047
3.907 views
Published on 16 December 2016
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2016.0504.038
3.815 views